Product Information
General Pharmaceuticals > Medicines for liver disorder
Complex Sseulgidam Soft Capsule
Precautions
1. doctor need to know if you have any of these conditions:
1) terrible biliary obstruction patients.
2) fulminant hepatic failure patients.
3) this product is contraindicated in those patients who have shown hypersensitivity to it.
4) pregnant or trying to get pregnant and breast-feeding.
5) Children (in animal tests, toxicity has been reported.)
6) large intestine and enteritis patients,diseases like Crohn's disease.
7) an unusual or allergic reaction to soybean oil.
8) an unusual or allergic reaction to soybeanorpeanut.
2. Do not take this medicine with any of the following medications:
1) this product may cause increase side effects. : oral medications for diabetes (tolbutamide).
2) this product may causeprevent absorption : cholestyramin, colestipol, Carbo Medicinalis, magnesium and Antacids
containing aluminum hydroxide.
3. Ask a doctor or pharmacist before use if you are:
1) patients with severe pancreatic diseasespatients.
2) Peptic ulcer disease patients.
3) Patients with gallstone diseasepatients.
4) Patients with hyperlipidemia, diabetes, high blood fat and fat metabolism disorder patients patient or patient who is injectedlipoid fluid carefully.
4. . If you feel you have experienced an allergic reaction,stop using this medicine and inform your doctor or dentist,pharmacist
immediately.Ask a doctoror pharmacist before use if you are taking medical precautions.
1) alimentary system : sometimesdiarrhea, nausea, vomiting, unusually stomach upset, constipation, chest pain, Stomach
discomfort etc.
2) allergic reactions likesometimes itching, unusually Rash etc.
3) other Side effects : unusually weak or tired,dizziness.
5. Other precautions:
1) do not use more than directed.
2) If you feel you have experienced an allergic reaction,stop using this medicine and inform your doctor or pharmacist immediately.
3) When taking this drug to patient with excessive body fat,it is recommended to check the plasma lipid index
beforehand. If the exam result regards vitro excretion of fat is insufficient, the drug injection must be controlled
accordingly. If patient is medicated with other intravenous lipid index, the amount of lipid mixed within the
medication as component must be considered and reduce the injection of the lipid index.
6. Storage Conditions
1) Keep out of the reach of children.
2) Keep container tightly closed. Discard unused medicine and used packaging carefully. Keep capsules in the original container. Do not store or place capsules in any other container.